Northwest Biotherapeutics Stock Price, News & Analysis (OTCMKTS:NWBO)

$0.32 -0.02 (-5.81 %)
(As of 01/21/2018 08:51 AM ET)
Previous Close$0.32
Today's Range$0.28 - $0.34
52-Week Range$0.14 - $0.49
Volume3.81 million shs
Average Volume1.69 million shs
Market Capitalization$106.99 million
P/E RatioN/A
Dividend YieldN/A

About Northwest Biotherapeutics (OTCMKTS:NWBO)

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.

Receive NWBO News and Ratings via Email

Sign-up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity Ratio-0.27%
Current Ratio0.03%
Quick Ratio0.03%


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$620,000.00
Price / Sales172.57
Cash FlowN/A
Price / CashN/A
Book Value($0.17) per share
Price / Book-1.91


Trailing EPS($0.46)
Net Income$-80,210,000.00
Net Margins-20,493.60%
Return on EquityN/A
Return on Assets-128.30%


Outstanding Shares329,710,000

Northwest Biotherapeutics (OTCMKTS:NWBO) Frequently Asked Questions

What is Northwest Biotherapeutics' stock symbol?

Northwest Biotherapeutics trades on the OTCMKTS under the ticker symbol "NWBO."

How were Northwest Biotherapeutics' earnings last quarter?

Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) posted its quarterly earnings data on Monday, November, 20th. The biotechnology company reported ($0.06) EPS for the quarter. View Northwest Biotherapeutics' Earnings History.

Who are some of Northwest Biotherapeutics' key competitors?

Who are Northwest Biotherapeutics' key executives?

Northwest Biotherapeutics' management team includes the folowing people:

  • Linda F. Powers, Chairperson of the Board, President, Chief Executive Officer (Age 59)
  • Leslie J. Goldman, Senior Vice President - Business Development (Age 70)
  • Anthony E. Maida Ph.D., Senior Vice President - Clinical Research (Age 61)
  • Marnix L. Bosch Ph.D, Chief Technical Officer (Age 55)
  • Alton L. Boynton Ph.D., Chief Scientific Officer, Director (Age 71)
  • Susan B. Bayh, Independent Director (Age 55)
  • Cofer Black, Independent Director
  • Robert A. Farmer, Independent Director (Age 75)
  • Jerry J. Jasinowski, Independent Director (Age 72)
  • Navid Malik, Independent Director (Age 46)

How do I buy Northwest Biotherapeutics stock?

Shares of Northwest Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Northwest Biotherapeutics' stock price today?

One share of Northwest Biotherapeutics stock can currently be purchased for approximately $0.32.

How big of a company is Northwest Biotherapeutics?

Northwest Biotherapeutics has a market capitalization of $106.99 million and generates $620,000.00 in revenue each year. The biotechnology company earns $-80,210,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Northwest Biotherapeutics employs 16 workers across the globe.

How can I contact Northwest Biotherapeutics?

Northwest Biotherapeutics' mailing address is 4800 MONTGOMERY LANE SUITE 800, BETHESDA MD, 20814. The biotechnology company can be reached via phone at 240-497-9024 or via email at [email protected]

MarketBeat Community Rating for Northwest Biotherapeutics (NWBO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Northwest Biotherapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Northwest Biotherapeutics (OTCMKTS:NWBO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/A$0.61$0.61
Price Target Upside: N/AN/A26.51% downside26.51% downside

Northwest Biotherapeutics (OTCMKTS:NWBO) Consensus Price Target History

Price Target History for Northwest Biotherapeutics (OTCMKTS:NWBO)

Northwest Biotherapeutics (OTCMKTS:NWBO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
12/15/2016S&P Equity ResearchLower Price Target$0.73 -> $0.61View Rating Details
(Data available from 1/21/2016 forward)


Northwest Biotherapeutics (OTCMKTS:NWBO) Earnings History and Estimates Chart

Earnings by Quarter for Northwest Biotherapeutics (OTCMKTS:NWBO)

Northwest Biotherapeutics (OTCMKTS NWBO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/20/2017Q3 2017($0.06)ViewN/AView Earnings Details
8/21/2017Q2 2017($0.05)ViewN/AView Earnings Details
5/15/2017Q1 2017($0.08)ViewN/AView Earnings Details
4/17/2017Q4 2016($0.20)ViewN/AView Earnings Details
11/10/2016Q3 2016($0.28)ViewN/AView Earnings Details
8/9/2016Q2 2016($0.29)($0.20)ViewN/AView Earnings Details
5/11/2016Q1 2016($0.25)($0.20)ViewN/AView Earnings Details
3/15/2016Q4 2015($0.26)ViewN/AView Earnings Details
11/9/2015Q3 2015($0.33)($0.16)ViewN/AView Earnings Details
8/10/2015Q2 2015($0.32)($0.54)$0.20 million$0.39 millionViewN/AView Earnings Details
5/11/2015Q1 2015($0.32)($0.34)ViewN/AView Earnings Details
11/19/2014Q3 2014($0.44)($0.58)ViewN/AView Earnings Details
8/15/2014Q2 2014($0.29)($0.53)ViewN/AView Earnings Details
5/15/2014Q1 2014($0.33)($0.46)$0.20 millionViewN/AView Earnings Details
4/1/2014Q4 2013($0.33)($1.84)ViewN/AView Earnings Details
11/15/2013Q3 2013($0.47)($0.65)ViewN/AView Earnings Details
8/14/2013Q2 2013($0.47)($0.40)ViewN/AView Earnings Details
5/15/2013Q1 2013($0.45)($0.54)ViewN/AView Earnings Details
4/8/2013Q4 2012($2.14)ViewN/AView Earnings Details
11/14/2012Q3 2012($0.82)($1.50)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.96)ViewN/AView Earnings Details
5/21/2012Q1 2012($0.80)($1.06)ViewN/AView Earnings Details
4/13/2012Q4 2011($2.16)ViewN/AView Earnings Details
11/14/2011Q3 2011$0.06ViewN/AView Earnings Details
8/15/2011Q2 2011($2.35)ViewN/AView Earnings Details
5/20/2011Q1 2011($1.74)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Northwest Biotherapeutics (OTCMKTS:NWBO) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Northwest Biotherapeutics (OTCMKTS:NWBO)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Northwest Biotherapeutics (OTCMKTS NWBO)

No insider trades for this company have been tracked by


Northwest Biotherapeutics (OTCMKTS NWBO) News Headlines


SEC Filings

Northwest Biotherapeutics (OTCMKTS:NWBO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Northwest Biotherapeutics (OTCMKTS:NWBO) Income Statement, Balance Sheet and Cash Flow Statement


Northwest Biotherapeutics (OTCMKTS NWBO) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.